agilon health, inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $6.1B | $4.3B | $2.4B | $1.5B |
| Operating income | -$463.2M | -$292.1M | -$232.1M | -$105.4M | -$372.2M |
| Operating expenses | — | — | — | $2.8B | $2.2B |
| Cash from operations | -$105.8M | -$57.8M | -$156.2M | -$130.8M | -$148.2M |
| Capital expenditure | $13.2M | $13.3M | $15.8M | $15.4M | $6.6M |
| Free cash flow | -$119.0M | -$71.0M | -$172.0M | -$146.2M | -$154.7M |
| Share repurchases | $0 | $0 | $200.0M | $0 | $0 |
| Impairments | $36.1M | $3.6M | $0 | $0 | — |
| Total assets | $1.3B | $1.7B | $1.7B | $1.7B | $1.6B |
| Total liabilities | $1.1B | $1.3B | $1.1B | $656.9M | $494.7M |
| Total debt | $35.0M | — | $38.8M | — | — |
Shares outstanding 16.7M · Free float 97.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.